Healthcare regulatory affairs agency appoints senior consultant to expand reach into medical devices market

10 November 2022

Woodley BioReg excited to attend MEDICA Trade Fair 2022

Medical Devices and Pharmaceutical Equipment manufacturers will meet in Düsseldorf from 14 – 17 November 2022 during the MEDICA...

01 November 2022

Biosimilar Experts Roundtable Discussions Go Live!

Dr Ash Ramzan, our principal consultant, recently took part in a Biosimilar Experts Roundtable Discussion hosted by biosimilar...

28 October 2022

Woodley BioReg to attend CPHI trade show in Frankfurt

Once again, a number of colleagues will attend the respected CPHI Worldwide Exhibition in Frankfurt on the 1-3...

24 October 2022

Woodley BioReg appoints Faith for PR support

Woodley BioReg is delighted to have partnered with Brighouse-based communications agency Faith to manage all communications, bolster its...

29 September 2022

Combination products: regulation surrounding medical devices that utilise drug substances

Drug-device combination products are increasingly prevalent in modern medicine, and include a range of products such as medical...

16 September 2022

Celebrating 21 years of Woodley BioReg

A 21st birthday is a momentous milestone, so that’s why the Woodley BioReg team went all out over...

16 September 2022

Medical devices: what are they, and how do we know that they’re safe?

In this instalment of In conversation with, we chat to Bryan Lister, our senior regulatory affairs consultant specialising...

21 July 2022

What is the UKCA mark, and how does it differ to CE marking?

As with many things post-Brexit, conformity marking of medical devices and IVDs has become much more complex for...

08 July 2022

What is regulatory affairs in the healthcare sector, and what does it consist of?

Given the rapidly changing environments, roles and responsibilities recently, we take a minute to just remind ourselves and...